RecruitingNCT06781359
Study on Plasmablastic Lymphoma Patients
Studying Plasmablastic lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Principal Investigator
- Alessia Castellino, MDUO Ematologia, AO Santa Croce e Carle, Cuneo - Italy
- Enrollment
- 200 enrolled
- Eligibility
- 15 years · All sexes
- Timeline
- 2025 – 2028
Study locations (23)
- IRCCS Centro di Riferimento Oncologico di Aviano, Divisione di Oncologia e dei Tumori immuno-correlati, Aviano, PN, Italy
- Ospedale C.e G. Mazzoni, U.O.C. di Ematologia, Ascoli Piceno, Italy
- ASST Spedali Civili di Brescia, Ematologia, Brescia, Italy
- A.O. S. Croce e Carle, S.C. di Ematologia e Trapianto di Midollo Osseo, Cuneo, Italy
- Azienda Ospedaliera Universitaria Careggi, Unità funzionale di Ematologia, Florence, Italy
- ASST -Fatebenefratelli - Polo Luigi Sacco Oncologia, Milan, Italy
- ASST Grande Ospedale Metropolitano Niguarda, SC Ematologia, Milan, Italy
- Istituto Scientifico San Raffaele, Unità Linfomi - Dipartimento Oncoematologia, Milan, Italy
- Ospedale Maggiore Policlinico - Fondazione IRCCS Ca' Granda, Ematologia, Milan, Italy
- Fondazione IRCCS San Gerardo dei Tintori, Ematologia, Monza, Italy
- AOU Maggiore della Caritа di Novara, SCDU Ematologia, Novara, Italy
- Azienda Ospedaliera Universitaria di Padova, Ematologia, Padua, Italy
- Presidio ospedaliero A. Tortora, U.O. Onco-ematologia, Pagani, Italy
- Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova, Ematologia, Reggio Emilia, Italy
- Azienda Ospedaliera Universitaria Sant' Andrea, Ematologia, Roma, Italy
- +8 more locations on ClinicalTrials.gov
Collaborators
AIL Roma - Italia · AIL Cuneo - Italia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06781359 on ClinicalTrials.govOther trials for Plasmablastic lymphoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04915248Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.Fondazione Italiana Linfomi - ETS
- RECRUITINGEARLY PHASE1NCT04139304A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaAIDS Malignancy Consortium
- ACTIVE NOT RECRUITINGPHASE1NCT01961063Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin LymphomaCity of Hope Medical Center